Sunbird Bio

📍 Cambridge, United States🗓 Founded 2021👥 33 employees💰 Last funded May 2020
Biotechnology Research🌐 sunbirdbio.com
Website LinkedIn
Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care. Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Spain
1
Investor activity2015–2020 · investors recorded per year
201512019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sunbird Bio?
Sunbird Bio has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Sunbird Bio last raise funding?
The most recent investment in Sunbird Bio recorded on gritt.io was in May 2020.
When was Sunbird Bio founded?
Sunbird Bio was founded in 2021.
What industry is Sunbird Bio in?
Sunbird Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sunbird Bio based?
Sunbird Bio is headquartered in Cambridge, United States.